What is new regarding the treatment of dyslipidemia in the 2019 European Society of Cardiology Guidelines?

Abstract

Despite considerable improvements in medical care over the past 25 years, cardiovascular disease (CVD) remains a major public health challenge. Dyslipidemias are one of the topics of greatest interest in cardiology. Decreasing serum cholesterol level is a central objective for preventing cardiovascular events. The current European Society of Cardiology guidelines recommend evaluation of the cardiovascular risk, treatment decisions being based on this risk, and clinician–patient discussion about the risk (shared decision making).

Keywords

• atherosclerosis
• cardiovascular risk
• dyslipidemia
• ldl-cholesterol
• triglycerides